dyslipidemia
美 
英
例句
HbA1c, aging, dyslipidemia, insulin resistance are found to be significant independent risk factors of carotid atherosclerosis.
糖基化血紅蛋白、增齡、血脂異常、胰島素抵抗是頸動脈粥樣硬化的重要因素。
To analyze the correlation between the main syndrome elements of T2DM with dyslipidemia patients and physical and biochemical indexes.
分析T2DM合并血脂異常人群主要證候要素與理化指標之間的關系。
Other risk factors are smoking, dyslipidemia, proteinuria, glomerular hyperfiltration and dietary factors.
其他的風險因素包括：吸煙、血脂異常、蛋白尿、腎小球高濾過和飲食因素。
Results the main risk factors of DN are disease producing pattern, hypertension, hyperglycemia and dyslipidemia.
結果DN危險因素主要有不良生活方式、高血壓、高血糖及血脂異常等。
Besides, CHD is a high risk factor to cause ischemic stroke and dyslipidemia is to hemorrhagic stroke for the elder age group.
此外，冠心病對缺血性卒中的危險性大，血脂異常對高年齡人群的出血性卒中危險更大。
The acute mania cohort also had a higher prevalence of dyslipidemia and diabetes, he added.
他指出，急性躁癥世代的血脂異常和糖尿病盛行率也較高。
To analyze the directory effect of systematic methodology principle in prophylaxis and treatment of dyslipidemia.
分析系統思維方法主要基本原則在血脂異常綜合防治中的指導性作用。
The strategies are reviewed for various types of dyslipidemia in various stages of chronic kidney disease in this paper.
本文對不同階段的慢性腎臟疾病病人在各種血脂異常時的調脂治療策略作一綜述。
Both body mass index and dyslipidemia were independently relevant with chronic inflammation in PD patients.
而身體質量指數及血脂異常與腹膜透析病患的慢性炎癥有明顯相關。
And the group of dyslipidemia had more number, severe and diffuse vascular plagues than those of normal lipidemia.
其中血脂異常者和血脂正常者相比，血管病變的數目更多，程度更重，范圍更彌漫。
Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD).
慢性腎臟病（CKD）患者動脈高血壓和血脂異常。
But the number of dyslipidemia patients reaching lipid goals is low in the clinic.
但在臨床實踐中，血脂異常病人的真正達標率卻還很低。
What is the relationship between isolated post prandial dyslipidemia and the risk of cardiovascular events in diabetic patients?
那么如何看待糖尿病患者單純餐后血脂異常與心血管事件風險的相關？
The results were not modified by initial folate status, MTHFR C677T genotype, dyslipidemia, or self-reported vascular disease.
結果沒有被最初的葉酸狀況、MTHFRC677T基因型、脂血或self-reported血管疾病所修飾。
Conclusion Dyslipidemia exists in the IFG patients.
結論新診斷的IFG患者已經存在血脂代謝異常。
International Diabetes: How does insulin resistance affect the development of dyslipidemia?
《國際糖尿病》：胰島素抵抗如何對血脂產生影響？
Conclusion: Jiangzhi Huoxue Yin had definited regulatory effect on the blood lipids and clinical symptom in patients with dyslipidemia.
結論：降脂活血飲對痰瘀互結證血脂異常患者的臨床癥狀及血脂有一定的調理作用。
Therefore, those who have dyslipidemia, but also for lowering therapy.
因此有血脂紊亂者，還應進行調脂治療。
Objective: To study the regulatory effect of compound Jiangzhi Huoxue Yin on blood lipids in patients with primary dyslipidemia.
目的：探討降脂活血飲對痰瘀互結證血脂異常的調節作用。
Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia
脂類代謝中的核受體：血脂障礙的心臟靶向作用
Clinical study of pravastatin in treatment of dyslipidemia after renal transplantation
普伐他汀治療腎移植術后血脂異常的臨床研究
Clinical efficacy of an intensive atorvastatin therapy in coronary heart disease patients with dyslipidemia
阿托伐他汀強化治療冠心病患者血脂異常的臨床療效
Study of the Therapy Effects of Low-intensity Laser Rhinal Radiation on Dyslipidemia
低強度激光鼻腔照射對血脂異常作用的研究
New recognition of a role of dyslipidemia and lipid-lowing treatment in pathogenesis of renal disease
對腎臟疾病中脂質異常與降脂治療作用的新認識
Comparative study on prevalence rate of dyslipidemia among Korean-Chinese nationality and Han nationality
朝鮮族及漢族居民血脂異常分布特征比較研究
Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus
針對控制不良的高血壓、血脂紊亂和糖尿病的治療修正
Clinical observation of relativity between cerebral infarction and dyslipidemia in patients with diabetes mellitus
糖尿病合并腦梗死與血脂異常相關性的臨床觀察
Dyslipidemia and the cardiovascular complications in patients with maintaining hemodialysis
血脂代謝紊亂與維持性血液透析患者的心血管并發癥
Analysis of dyslipidemia, fatty liver and elevated glutamate-pyruvate transaminase of in-hospital aircraft pilots
住院軍隊飛行人員血脂異常脂肪肝和谷丙轉氨酶升高的分析
Analyzing Dyslipidemia of Coronary Heart Disease by Capillary Isotachophoresis
毛細管等速電泳法分析冠心病血脂異常
Lipoprotein Lipase Mutation Predisposes Carriers to Severe Dyslipidemia
脂蛋白脂酶變異易產生嚴重血脂紊亂基因攜帶者
The Relationship Between Insulin Resistance And dyslipidemia in Coronary Heart Disease Patients
冠心病患者胰島素抵抗與血脂關系的研究
Study on Clinical Characteristics of the Relationship between Dyslipidemia and hyperglycemia in Patients with Type 2 Diabetes
2型糖尿病患者糖代謝紊亂與脂代謝紊亂關系的臨床研究
Repeated oral treatment with polysaccharide sulfate reduces insulin resistance and dyslipidemia in diabetic dyslipidemic rat model
藻酸雙酯鈉改善模型大鼠的胰島素抵抗和血脂異常
Nephrotoxicity induced by dyslipidemia in children with primary nephritic syndrome
原發性腎病綜合征患兒血脂代謝紊亂的腎毒性作用
Relationship between insulin resistance and dyslipidemia in aged patients with diabetes
老年糖尿病胰島素抵抗與脂代謝紊亂
The clinic study on the relationship between insulin resistance and dyslipidemia in coronary heart disease
冠心病患者胰島素抵抗與血脂、載脂蛋白異常的關系
Prevalence of hypertension, diabetes and dyslipidemia of the survey population (over 15 years old) was 18. 5%, 4. 0% and 6. 3% respectively.
監測人群中15歲及以上成年人高血壓、糖尿病、血脂異常患病率依次為18.5%、4.0%和6.
Survey of plasma lipid value in children in Beijing area and the changes of gaseous molecule-hydrogen sulfide in the ones with dyslipidemia
北京地區部分兒童血脂現狀調查及氣體分子硫化氫在血脂紊亂中的變化
Relationship between polymorphism of microsomal triglyceride transfer protein gene and dyslipidemia in type 2 diabetics
微粒體甘油三酯轉移蛋白基因多態性與2型糖尿病血脂紊亂的關系
